Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramiro Garzon

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Blood Advances|January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic modelLotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Blood|December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemiaShujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemiaXiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid LeukemiaMarius Bill, Aparna Pathmanathan, Malith Karunasiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2017
Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid LeukemiaDaniela Di Marcantonio, Esteban Martinez, Simone Sidoli, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Blood|July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaPearlly Yan, David Frankhouser, Mark Murphy, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Blood Advances|January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic modelLotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Blood|December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemiaShujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemiaXiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid LeukemiaMarius Bill, Aparna Pathmanathan, Malith Karunasiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2017
Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid LeukemiaDaniela Di Marcantonio, Esteban Martinez, Simone Sidoli, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Blood|July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaPearlly Yan, David Frankhouser, Mark Murphy, et al.
Pageof 14